To the Editor: Cutaneous leishmaniasis is well established in the Mediterranean basin. However, the disease is spreading and new foci have been reported (1) (2) (3) . Because of climate change, it is feasible that vector-borne diseases such as cutaneous leishmaniasis may spread northward into Europe (4) . We report a patient who acquired cutaneous leishmaniasis while on holiday in Jura, France.
A previously healthy 49-yearold white man from the Netherlands traveled to France in August 2007. During August 2-17, he stayed at a camp site in Clairvaux-les-Lacs in a forested area near a lake. He made regular trips by foot in the surrounding area. Three months later, he noticed a swelling on his nose. In February 2008, he consulted a dermatologist who treated him twice with cryotherapy under a diagnosis of actinic keratosis, after which the lesion nearly disappeared.
Three months later, the patient again consulted the dermatologist when the lesion recurred. A biopsy result from the lesion was interpreted as an acute ulcerative infl ammation without further specifi cation. Treatment was continued with imiquimod 5% cream followed by erythromycin 2% cream with clobetasol 0.05% ointment. Because of a lack of improvement, this treatment regimen was alternated with tacrolimus 0.1% ointment until May 2008.
In November 2008, he consulted another dermatologist, who obtained a biopsy specimen in which a large number of intracellular microorganisms compatible with leishmaniasis were observed in histiocytes. The patient was then referred to the Department of Dermatology at the Academic Medical Centre in Amsterdam. On examination, we found a plaque with a crusting surface and an erythematous border on the bridge of the nose (Figure, panel A) . Regional lymph nodes were not palpable.
Revised histopathologic examination of the biopsy specimen showed a dermal infl ammatory infi ltrate of histiocytes containing numerous intracellular Leishmania amastigotes and epithelioid cells, lymphocytes, and few plasma cells (Figure, There are several reports of leishmaniasis acquired in Europe in locations north of the Mediterranean basin. Naucke et al. (5) reported 11 cases of endemically acquired leishmaniasis (human, canine, feline, and equine infections) in Germany since 1991. In 1992, a child with visceral leishmaniasis was described who had spent weekends and holidays near Calais, France (6) .
We assume that our patient acquired cutaneous leishmaniasis in mainland Europe at 46°N. He had not visited leishmaniasis-endemic areas before this holiday in the French Jura.
Cutaneous leishmaniasis in France is found mainly in the region Pyrénées-Orientales, with 2 sandfl ies, Phlebotomus ariasi and Phlebotomus perniciosus, as vectors (7). One of the causative factors for the northward emergence of leishmaniasis in Europe is the spread of visceral and cutaneous leishmaniasis from disease-endemic areas in the Mediterranean to neighboring temperate areas with vectors without disease (8) . A northward spread of leishmaniasis with an extension of the geographic range of Ph. perniciosus and Ph. neglectusus sandfl ies has been found in Italy (9), and northward (Transphlebotomus) mascittii into Germany (5) . It has been hypothesized that sandfl ies have always been sporadically present in central Europe, but that climate change will lead to extended distribution (10) .
It is tempting to assume that climate change resulted in cutaneous leishmaniasis at 46°N in France. In any event, our case and those reported by others should make clinicians aware of the possibility of cutaneous leishmaniasis outside the well-known disease-endemic areas.
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To the Editor: Leishmaniasis, an infectious disease caused by parasites of the genus Leishmania, is transmitted to humans through the bite of a female sandfl y. The 3 forms of leishmaniasis are visceral (VL) and cutaneous (CL), which are typical of the Old World, and mucocutaneous leishmaniasis, which occurs primarily in Central and South America. VL (also called kala-azar) is caused by species of the L. donovani complex (including L. infantum), and CL is mainly caused by L. major or L. tropica (1) . In Italy, Direct sequencing of the Leishmania aDNA identifi ed a strain with high homology to L. infantum. Accordingly, we obtained a 98% concordance rate between our sequence and that of L. infantum (expect rate 6e-47, identity rate 113/118) (online Appendix Figure) . The rates for other Leishmania species indicated that concordance for those species was less probable.
For the protein assay, fractionated proteins from a lysate of late-logphase promastigotes of L. infantum ZMON-1 (World Health Organization
